diaxxo AG

Diaxxo is a start-up originated at ETH Zürich, where in the past 4 years we have developed and prototyped an innovative Point-of-Care Polymerase Chain Reaction (PCR) device. Our vision is to bring the power of molecular diagnostics to Point-of-Care settings, thanks to our new pre-loaded test kits that allow for simpler and faster sample preparation. In 2020 our devices have been used by more than 250 laypeople for the rapid detection of COVID-19 in a field study at ETH Zürich. Our systems are currently being tested at the Swiss Tropical and Public Health Institute (Swiss TPH) and at the Tierspital Zürich.